GGI
INSM icon

GordonMD Global Investments’s Insmed INSM Stock Holding History

GordonMD Global Investments’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.05M Hold
28,587
– – 1.47% 16
2026
Q1 		$4.67M Hold
28,587
– – 3.26% 12
2025
Q4 		$4.98M Buy
+28,587
New +$5.22M 3.57% 11

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

GordonMD Global Investments's INSM Position: Q2 2026 in Review

GordonMD Global Investments held its Insmed (INSM) position steady in Q2 2026 at 28,587 shares worth $3.05M. The position accounts for 1.47% of the portfolio, ranked #16.

GordonMD Global Investments first reported a position in INSM in Q4 2025 and has held it in 3 quarters since. The position peaked at $4.98M in Q4 2025. 664 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • GordonMD Global Investments held 28,587 shares of Insmed worth $3.05M as of Q2 2026.
  • GordonMD Global Investments left its Insmed share count unchanged in Q2 2026.
  • Insmed made up 1.47% of GordonMD Global Investments's portfolio in Q2 2026, its #16 holding.
  • GordonMD Global Investments first reported a position in Insmed in Q4 2025 and has held it in 3 quarters since.
  • GordonMD Global Investments's Insmed position peaked at $4.98M in Q4 2025.
  • 664 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on GordonMD Global Investments's 13F filing for Q2 2026, filed 14 Aug 2026.